Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential
Ingrid Spaan, Reinier Raymakers, Anja van de Stolpe, et al.
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Targeting the Wnt/β-catenin signaling pathway in cancer
Ya Zhang, Xin Wang
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 1072
Wnt/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer
Yue Wang, Lixin Zheng, Wenjing Shang, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 11, pp. 2190-2202
Open Access | Times Cited: 266
WNT Signaling in Tumors: The Way to Evade Drugs and Immunity
Elena Martín‐Orozco, Ana Sanchez-Fernandez, Irene Ortiz-Parra, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 237
The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies
Vivek Kumar, Mohit Vashishta, Lin Kong, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 177
The Wnt signaling pathway: a potential therapeutic target against cancer
Noyel Ghosh, Uday Hossain, Ankita Mandal, et al.
Annals of the New York Academy of Sciences (2019) Vol. 1443, Iss. 1, pp. 54-74
Closed Access | Times Cited: 109
Wnt pathway modulators in cancer therapeutics: An update on completed and ongoing clinical trials
Ann Neiheisel, Manpreet Kaur, Nancy Ma, et al.
International Journal of Cancer (2021) Vol. 150, Iss. 5, pp. 727-740
Open Access | Times Cited: 73
NSD2 overexpression drives clustered chromatin and transcriptional changes in a subset of insulated domains
Priscillia Lhoumaud, Sana Badri, Javier Rodriguez-Hernaez, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 68
RETRACTED ARTICLE: Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/β-catenin signaling pathway by regulating WNT2
Dianhui Xiu, Guifeng Liu, Shao‐Nan Yu, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 55
Signaling Pathway Mediating Myeloma Cell Growth and Survival
Teru Hideshima, Kenneth C. Anderson
Cancers (2021) Vol. 13, Iss. 2, pp. 216-216
Open Access | Times Cited: 54
Silybum marianum total extract, silymarin and silibinin abate hepatocarcinogenesis and hepatocellular carcinoma growth via modulation of the HGF/c-Met, Wnt/β-catenin, and PI3K/Akt/mTOR signaling pathways
Nour Y. S. Yassin, Sameh AbouZid, Asmaa M. El-Kalaawy, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112409-112409
Open Access | Times Cited: 45
Retraction Note: Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/β-catenin signaling pathway by regulating WNT2
Dianhui Xiu, Guifeng Liu, Shao‐Nan Yu, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 42
Pathogenesis and Treatment of Myeloma-Related Bone Disease
Yuh‐Ching Gau, Tsung‐Jang Yeh, Chin‐Mu Hsu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3112-3112
Open Access | Times Cited: 30
Hematological Diseases and Osteoporosis
Agostino Gaudio, Anastasia Xourafa, R Rapisarda, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3538-3538
Open Access | Times Cited: 49
Quantitative Measurement of Functional Activity of the PI3K Signaling Pathway in Cancer
Anja van de Stolpe
Cancers (2019) Vol. 11, Iss. 3, pp. 293-293
Open Access | Times Cited: 37
IDH2 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in multiple myeloma
Sha Song, Fan Gao, Qi Li, et al.
Oncogene (2021) Vol. 40, Iss. 35, pp. 5393-5402
Closed Access | Times Cited: 31
Effects of saponins from Chinese herbal medicines on signal transduction pathways in cancer: A review
Mingtao Zhu, Yanping Sun, Haodong Bai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Secondary osteoporosis
Gregory R. Emkey
Elsevier eBooks (2024)
Closed Access | Times Cited: 4
Morphogens and Cell-Derived Structures (Exosomes and Cytonemes) as Components of the Communication Between Cells
Stavros Chideriotis, Alkmini T. Anastasiadi, Vassilis L. Tzounakas, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 881-881
Open Access
MEIS1 knockdown upregulates WNT signaling pathway genes in esophageal squamous cell carcinoma
Nayyerehalsadat Hosseini, Mohammad Mahdi Forghanifard
BMC Medical Genomics (2025) Vol. 18, Iss. 1
Open Access
Myeloma Bone Disease: Update on Pathogenesis and Novel Treatment Strategies
Sonia Vallet, Julia-Marie Filzmoser, Martin Pecherstorfer, et al.
Pharmaceutics (2018) Vol. 10, Iss. 4, pp. 202-202
Open Access | Times Cited: 37
Wnt signaling: A prospective therapeutic target for chronic pain
Ya‐Qun Zhou, Xuebi Tian, Yuke Tian, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107984-107984
Closed Access | Times Cited: 25
Splicing factor arginine/serine‐rich 8 promotes multiple myeloma malignancy and bone lesion through alternative splicing of CACYBP and exosome‐based cellular communication
Yuanjiao Zhang, Xichao Yu, Rongze Sun, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 2
Open Access | Times Cited: 18
Integrating molecular subtype and CD8+ T cells infiltration to predict treatment response and survival in muscle-invasive bladder cancer
Bingyu Li, Kaifeng Jin, Zhaopei Liu, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 4
Open Access | Times Cited: 3
Predicting the Progression from Asymptomatic to Symptomatic Multiple Myeloma and Stage Classification Using Gene Expression Data
Nestoras Karathanasis, George M. Spyrou
Cancers (2025) Vol. 17, Iss. 2, pp. 332-332
Open Access
Research advances in natural sesquiterpene lactones: overcoming cancer drug resistance through modulation of key signaling pathways
Chi Teng, Jiawen Chen, Lisha Shen, et al.
Cancer Drug Resistance (2025)
Open Access
Page 1 - Next Page

Scroll to top